メニュー

参考資料一覧

  1. 国立がん研究センターがん情報サービス「がん登録・統計」
  2. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle, 1997-2015. Available at http://www.genetests.org. Accessed Apr 5th, 2020.
  3. Monozawa Y et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nature Communications 2018; 9(1): 4083
  4. Hirasawa A et al. Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. Oncotarget 2017; 8(68): 112258-112267
  5. Enomoto T et al. The First Japanese Nationwide Multicenter Study of BRCA Mutation Testing in Ovarian Cancer: CHARacterizing the cross-sectionaL Approach to Ovarian Cancer geneTic of BRCA (CHARLOTTE). Int J Gynecol Cancer 2019; 29(6): 1043-1049
  6. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian and Pancreatic. Version 1.2020
  7. 厚生労働科学研究がん対策推進総合研究事業「わが国における遺伝性乳癌卵巣癌の臨床遺伝学的特徴の解明と遺伝子情報を用いた生命予後の改善に関する研究班編 遺伝性乳癌卵巣癌症候群(HBOC)診療の手引き2017年版 Available at http://johboc.jp/guidebook2017/
  8. Kuchenbaecker KB et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017; 317: 2402-2416
  9. Valachis A et al. Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis. Breast Cancer Research Treatment 2014; 144(3): 443-455

【その他の参考資料】